Lingyong Cao

Prof. Dr. Lingyong Cao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in Phytomedicine
Verified
Journal Article
Closed access
WLWanting Liu
Wanting Liu
YZYikai Zhang
Yikai Zhang
MZMingze Zheng
Mingze Zheng
YYYixiao Ye
Yixiao Ye
MSMujia Shi
Mujia Shi
LWLEI WANG
LEI WANG

12 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CZChuanjie Zheng
Chuanjie Zheng
JYJianming Yin
Jianming Yin
LWLinyue Wu
Linyue Wu
ZHZhanhui Hu
Zhanhui Hu
YZYikai Zhang
Yikai Zhang
YQYiqian Qu
Yiqian Qu
Depression impairs self-management in diabetic patients, exacerbates insulin resistance, and elevates glycated hemoglobin (HbA1c) levels, thereby increasing diabetes risk. This study analyzed data from 30,386 participants in the National Health and Nutrition Examination Survey (NHANES), assessing depression severity using the 9-item Patient Health Questionnaire (PHQ-9) and evaluating diabetes status through clinical markers such as HbA1c, random blood glucose, and fasting blood glucose. Participants were stratified by depression severity and diabetes status to examine the relationship between depression and diabetes risk. We applied descriptive statistics, logistic regression models, subgroup analyses, and restricted cubic spline (RCS) modeling to explore this association. The results revealed that greater depression severity was significantly associated with increased diabetes incidence, elevated HbA1c, fasting glucose, and insulin levels. Multivariate regression analysis confirmed a consistent positive correlation between depression severity and diabetes risk. Subgroup analyses further identified significant relationships between depression and various demographic and behavioral factors, including gender, race, BMI, smoking status, and prediabetic conditions. Additionally, the RCS model demonstrated a clear increase in diabetes risk with rising PHQ-9 scores. In conclusion, our study demonstrates that the severity of depression is positively correlated with the risk of diabetes, and this association may be closely linked to various glycemic and lipid metabolic parameters.

27 December 2024 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
YCYing Chang
Ying Chang
JYJianming Yin
Jianming Yin
JLJian-Min Li
Jian-Min Li
CLChang Liu
Chang Liu
LCLingyong Cao
Lingyong Cao
LSLIN SHUYUAN SHUYUAN
LIN SHUYUAN SHUYUAN

1 January 2022
Verified
Journal Article
Closed access
YDY. Ding
Y. Ding
YLY. Liu
Y. Liu
YQY. Qu
Y. Qu
MLM. Lin
M. Lin
FDF. Dong
F. Dong
LSLIN SHUYUAN SHUYUAN
LIN SHUYUAN SHUYUAN

18 December 2024 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
JYJianming Yin
Jianming Yin
CZChuanjie Zheng
Chuanjie Zheng
ZLZhan Li
Zhan Li
YCYing Chang
Ying Chang
LCLingyong Cao
Lingyong Cao
YQYiqian Qu
Yiqian Qu
The uric acid to high-density lipoprotein cholesterol ratio (UHR) has emerged as a novel metabolic marker and is proven to be associated with diabetes risk. However, there is still a lack of systematic research regarding its role in gender differences and underlying mechanisms. This study aims to assess the association of UHR with diabetes risk in the context of gender differences and to investigate its mediation effects through metabolic and inflammatory pathways. This study utilized data from NHANES 2005–2010 and included 6,843 adult participants. Multivariate logistic regression was employed to assess the association between UHR and diabetes risk, and restricted cubic spline (RCS) along with correlation analysis was applied to explore its relationship with metabolic risk factors. Multiple mediation analysis was conducted to evaluate the mediating effects of homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides (TG), and C-reactive protein (CRP) on the association between UHR and diabetes risk. In the overall population, UHR was significantly positively associated with diabetes risk, but gender-stratified analysis revealed a stronger predictive effect in women. In the unadjusted model, every unit increase in UHR was linked to an 18.6% increase in diabetes risk in women (p < 0.001). In the quartile analysis, women in the highest quartile showed an 8.49-fold increased risk of diabetes (OR = 8.494, 95% CI: 5.542–13.019, p < 0.001), whereas no significant association was observed in men (p > 0.05). Mediation analysis revealed that HOMA-IR was the main mediator of the relationship between UHR and diabetes risk, with mediation effects of 64.55%, 118.38%, and 39.09% in the overall population, men, and women, respectively. Additionally, the mediation effect of TG was stronger in men (36.78%) and weaker in women (17.31%). The mediation effect of CRP was relatively minimal across all groups, accounting for 7.62% in men and 2.67% in women. This study demonstrates that the association between UHR and diabetes risk exhibits gender differences, with higher diabetes risk observed in women, while men show stronger mediation effects in insulin resistance, lipid metabolism, and inflammatory response.

24 December 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
JLJieying Li
Jieying Li
YFYongfu Fan
Yongfu Fan
WTWenling Tu
Wenling Tu
LWLinyue Wu
Linyue Wu
YPYun Pan
Yun Pan
LCLingyong Cao
Lingyong Cao
Diabetes is a significant global health issue, causing extensive morbidity and mortality, and represents a serious threat to human health. Recently, the bioactive lipid molecule Sphingosine-1-Phosphate has garnered considerable attention in the field of diabetes research. The aim of this study is to comprehensively understand the mechanisms by which Sphingosine-1-Phosphate regulates diabetes. Through comprehensive bibliometric analysis and an in-depth review of relevant studies, we investigated and summarized various mechanisms through which Sphingosine-1-Phosphate acts in prediabetes, type 1 diabetes, type 2 diabetes, and their complications (such as diabetic nephropathy, retinopathy, cardiovascular disease, neuropathy, etc.), including but not limited to regulating lipid metabolism, insulin sensitivity, and inflammatory responses. This scholarly work not only unveils new possibilities for using Sphingosine-1-Phosphate in diabetes treatment but also offers fresh insights and recommendations for future research directions to researchers.